Is Neurocrine Biosciences, Inc. (NBIX) a Buy, Sell, or Hold?
NASDAQ : NBIX
Neurocrine Biosciences, Inc. — Institutional Ownership
$166.8 USD
-$18.7 (-10.08%)
- Volume
- 4.58M
- Average Volume
- 1.29M
- Market Capitalization
- $16.77B
- P/E Ratio
- 23.66
- Dividend Yield
- 0.00%
- Price Target
- $200.00
- Year High
- $186.12
- Year Low
- $122.14
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.87
Institutional Ownership Summary
Institutional Ownership %
4.39%
Investors Holding
260
change: -454 | last: 714
Increased Positions
160
change: -228 | last: 388
Reduced Positions
62
change: -154 | last: 216
New Positions
69
change: -16 | last: 85
Sold Positions
508
change: 389 | last: 119
Total Calls
1000
Total Puts
-
Put-Call Ratio
0.00
change: -204.8434 | last: 2.0484
Total Invested
736.26M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-30 | Vanguard Capital Management | 5.26M | 5.23% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-01-21 | JPMORGAN CHASE & CO. | 5.2M | 5.20% |
| 2025-05-14 | Dodge & Cox | 5.53M | 5.60% |
| 2025-04-28 | BlackRock, Inc. | 12.05M | 12.10% |
| 2025-03-06 | The Vanguard Group | 10.13M | 10.15% |
| 2025-02-05 | STATE STREET CORPORATION | 4.89M | 4.80% |
| 2024-10-17 | STATE STREET CORPORATION | 5.15M | 5.10% |
| 2022-02-14 | 52-0556948 | 4.36M | 4.50% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 8.79M | 9.26% |
| 2022-02-10 | EIN #00-0000000 | 7.45M | 7.80% |
| 2022-01-27 | (1) BlackRock, Inc. | 11.48M | 12.10% |
| 2022-01-26 | (1) BlackRock, Inc. | 11.48M | 12.10% |
| 2021-08-10 | FMR LLC | 3.78M | 3.99% |
| 2021-04-12 | EIN #00-0000000 | 9.44M | 10.00% |
| 2021-04-12 | (1) BlackRock, Inc. | 10.99M | 11.70% |
| 2021-02-16 | 95-1411037 | 13.0 | 4.30% |
| 2021-02-16 | 52-0556948 | 6.27M | 6.70% |
| 2021-02-11 | EIN #00-0000000 | 9.31M | 9.90% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 8.34M | 8.92% |
| 2021-01-29 | (1) BlackRock, Inc. | 7M | 7.50% |
| 2020-02-14 | Capital International Investors ** | 6.74M | 7.30% |
| 2020-02-14 | 52-0556948 | 7.29M | 7.90% |
| 2020-02-14 | Perceptive Advisors LLC | 3.61M | 3.90% |
| 2020-02-14 | Joseph Edelman | 3.61M | 3.90% |
| 2020-02-14 | Ltd. | 3.41M | 3.70% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 8.32M | 9.03% |
| 2020-02-10 | (1) BlackRock, Inc. | 6.59M | 7.20% |
| 2020-02-07 | FMR LLC | 7.43M | 8.06% |
| 2019-12-10 | FMR LLC | 8.47M | 9.19% |
| 2019-02-14 | 52-0556948 | 4.01M | 4.40% |
| 2019-02-13 | FMR LLC | 13.1M | 14.43% |
| 2019-02-13 | Abigail P. Johnson | 13.1M | 14.43% |
| 2019-02-11 | (1) BlackRock, Inc. | 4.98M | 5.50% |
| 2018-02-14 | 2 | 5.15M | 5.60% |
| 2018-02-14 | 52-0556948 | 6.23M | 7.00% |
| 2018-02-13 | FMR LLC | 13.27M | 15.00% |
| 2018-02-13 | Abigail P. Johnson | 13.27M | 15.00% |
| 2018-02-08 | (1) BlackRock, Inc. | 4.78M | 5.40% |
| 2017-09-08 | 2 | 4.66M | 5.30% |
| 2017-02-07 | 52-0556948 | 5.98M | 6.80% |
| 2017-01-25 | (1) BlackRock, Inc. | 5.26M | 6.10% |
| 2016-01-27 | (1) BlackRock, Inc. | 7.05M | 8.20% |
| 2015-02-13 | Abigail P. Johnson | 11.4M | 15.00% |
| 2015-02-13 | FMR LLC | 11.4M | 15.00% |
| 2015-02-13 | Edward C. Johnson 3d | 11.4M | 15.00% |
| 2015-01-23 | (1) BlackRock, Inc. | 6.35M | 8.40% |
| 2014-01-30 | (1) BlackRock, Inc. | 4.6M | 6.80% |
| 2013-02-14 | Mark N. Lampert | - | 0.00% |
| 2013-02-14 | BVF Investments, L.L.C. | - | 0.00% |
| 2013-02-14 | FMR LLC | 9.96M | 15.00% |
| 2013-02-14 | Edward C. Johnson 3d | 9.96M | 15.00% |
| 2013-02-14 | BVF Partners L.P. | - | 0.00% |
| 2013-02-14 | Biotechnology Value Fund, L.P. | - | 0.00% |
| 2013-02-14 | Biotechnology Value Fund II, L.P. | - | 0.00% |
| 2013-02-14 | Investment 10, L.L.C. | - | 0.00% |
| 2013-02-14 | BVF Inc. | - | 0.00% |
| 2013-02-14 | Perceptive Advisors LLC | 4.21M | 6.33% |
| 2013-01-30 | (1) BlackRock, Inc. | 3.85M | 5.79% |
| 2012-06-08 | (1) BlackRock, Inc. | 3.26M | 4.92% |
| 2012-02-14 | FMR LLC | 8.29M | 15.00% |
| 2012-02-14 | Edward C. Johnson 3d | 8.29M | 15.00% |
| 2011-10-12 | BVF Partners L.P. | 5.9M | 10.70% |
| 2011-10-12 | Biotechnology Value Fund, L.P. | 1.23M | 2.20% |
| 2011-10-12 | BVF Inc. | 5.9M | 10.70% |
| 2011-10-12 | Mark N. Lampert | 5.9M | 10.70% |
| 2011-10-12 | BVF Investments, L.L.C. | 3.51M | 6.40% |
| 2011-10-12 | Investment 10, L.L.C. | 403.5K | 1.00% |
| 2011-10-12 | Biotechnology Value Fund II, L.P. | 756.6K | 1.40% |
| 2011-02-14 | 04-2683227 | 2.17M | 3.96% |
| 2011-02-07 | (1) BlackRock, Inc. | 3.09M | 5.64% |
| 2010-05-10 | Edward C. Johnson 3d | 6.44M | 11.74% |
| 2010-05-10 | FMR LLC | 6.44M | 11.74% |
| 2010-04-14 | BVF Inc. | 5.4M | 9.90% |
| 2010-04-14 | BVF Investments, L.L.C. | 2.96M | 5.40% |
| 2010-04-14 | BVF Partners L.P. | 5.4M | 9.90% |
| 2010-04-14 | Investment 10, L.L.C. | 363.5K | 1.00% |
| 2010-04-14 | Mark N. Lampert | 5.4M | 9.90% |
| 2010-04-14 | Biotechnology Value Fund, L.P. | 1.23M | 2.30% |
| 2010-04-14 | Biotechnology Value Fund II, L.P. | 845K | 1.60% |
| 2010-02-12 | 04-2683227 | 2.2M | 5.61% |
| 2010-02-08 | (. | 2.03M | 5.18% |
| 2010-01-05 | VHCP Management, LLC | 4.78M | 10.90% |
| 2010-01-05 | Venrock Co-Investment Holdings, LLC | 739.9K | 1.70% |
| 2010-01-05 | Hove, Anders | 4.78M | 10.90% |
| 2010-01-05 | Venrock Healthcare Capital Partners, L.P. | 4.04M | 9.20% |
| 2010-01-05 | Roberts, Bryan | 4.78M | 10.90% |
| 2009-02-13 | 52-0556948 | 529.46K | 1.30% |
| 2009-02-09 | (. | 2.44M | 6.31% |
| 2008-02-14 | EIN #75-3019302 | - | 0.00% |
| 2008-02-12 | 52-0556948 | 2.21M | 5.70% |
| 2008-02-06 | (. | 2.93M | 7.72% |
| 2008-01-22 | BVF Partners L.P. | 2.93M | 7.70% |
| 2008-01-22 | Biotechnology Value Fund, L.P. | 665.1K | 1.80% |
| 2008-01-22 | Biotechnology Value Fund II, L.P. | 460K | 1.20% |
| 2008-01-22 | BVF Investments, L.L.C. | 1.61M | 4.20% |
| 2008-01-22 | Investment 10, L.L.C. | 196K | 0.50% |
| 2008-01-22 | BVF Inc. | 2.93M | 7.70% |
| 2008-01-10 | Edward C. Johnson 3d | 100.0 | 0.00% |
| 2008-01-10 | FMR LLC | 100.0 | 0.00% |
| 2007-12-20 | Peter Kolchinsky | 1.96M | 5.10% |
| 2007-12-20 | RA Capital Biotech Fund II, L.P. | 25415.0 | 0.10% |
| 2007-12-20 | RA Capital Management, LLC | 1.96M | 5.10% |
| 2007-12-20 | RA Capital Biotech Fund, L.P. | 1.93M | 5.00% |
| 2007-12-20 | Richard H. Aldrich | 1.96M | 5.10% |
| 2007-10-10 | Edward C. Johnson 3d | 3.18M | 8.38% |
| 2007-10-10 | FMR LLC | 3.18M | 8.38% |
| 2007-02-14 | FMR Corp. | 5.24M | 13.84% |
| 2007-02-14 | EIN #75-3019302 | 2.12M | 5.60% |
| 2007-02-14 | Edward C. Johnson 3d | 5.24M | 13.84% |
| 2007-02-14 | 52-0556948 | 1.85M | 4.80% |
| 2006-12-08 | 52-0556948 | 1.98M | 5.20% |
| 2006-06-12 | EIN #75-3019302 | 1.23M | 3.30% |
| 2006-02-14 | FMR Corp. | 3.76M | 10.19% |
| 2006-02-14 | Massachusetts Financial Services Company ("MFS") | 804.12K | 2.20% |
| 2006-02-14 | EIN #75-3019302 | 4.74M | 12.80% |
| 2006-02-14 | Edward C. Johnson 3d | 3.76M | 10.19% |
| 2006-02-14 | 52-0556948 | 4.42M | 11.90% |
| 2005-02-14 | Edward C. Johnson 3d | 4.4M | 12.07% |
| 2005-02-14 | Abigail P. Johnson | 4.4M | 12.07% |
| 2005-02-14 | FMR Corp. | 4.4M | 12.07% |
| 2005-02-14 | EIN #75-3019302 | 4.03M | 11.10% |
| 2005-02-14 | 52-0556948 | 4.58M | 12.50% |
| 2005-02-08 | Massachusetts Financial Services Company ("MFS") | 1.92M | 5.26% |
| 2004-08-10 | EIN #75-3019302 | 4.21M | 11.60% |
| 2004-02-17 | Abigail P. Johnson | 3.66M | 10.37% |
| 2004-02-17 | FMR Corp. | 3.66M | 10.37% |
| 2004-02-17 | EIN #75-3019302 | 2.49M | 7.10% |
| 2004-02-17 | Edward C. Johnson 3d | 3.66M | 10.37% |
| 2004-02-10 | 52-0556948 | 3.77M | 10.70% |
| 2003-02-14 | Edward C. Johnson 3d | 3.98M | 13.00% |
| 2003-02-14 | FMR Corp. | 3.98M | 13.00% |
| 2003-02-14 | Abigail P. Johnson | 3.98M | 13.00% |
| 2003-02-11 | 52-0556948 | 3.1M | 10.10% |
| 2003-02-10 | 52-0556948 | 3M | 9.80% |
| 2003-02-05 | 52-0556948 | 3M | 9.80% |
| 2002-02-22 | 52-0556948 | 2.28M | 7.60% |
| 2002-02-14 | Edward C. Johnson 3d | 2.79M | 9.47% |
| 2002-02-14 | FMR Corp. | 2.79M | 9.47% |
| 2002-02-14 | Abigail P. Johnson | 2.79M | 9.47% |
| 2002-02-11 | FMR Corp. | 3.86M | 13.00% |
| 2002-02-11 | Edward C. Johnson 3d | 3.86M | 13.00% |
| 2002-02-11 | 52-0556948 | 2.28M | 7.60% |
| 2002-02-11 | Abigail P. Johnson | 3.86M | 13.00% |
| 2001-04-19 | Deutsche Bank AG | 1.34M | 5.30% |
| 2001-04-10 | 52-0556948 | 2.65M | 10.50% |
| 2001-02-13 | Wells Fargo & Company | 1.17M | 5.40% |
| 2001-02-09 | 52-0556948 | 2.12M | 8.40% |
| 2001-02-09 | 52-0791372 | 1.15M | 4.50% |
| 2000-02-07 | 52-0791372 | 1.01M | 5.20% |
| 2000-02-07 | 52-0556948 | 1.69M | 8.80% |
| 1999-02-09 | 52-0791372 | 985K | 5.40% |
| 1999-02-09 | 52-0556948 | 2.21M | 12.10% |
| 1998-05-07 | 52-0556948 | 1.77M | 10.30% |
NBIX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $141.83 | 99.5M | $14.11B | $713M | $415.3M | $13.81B |
| 2024-12-31 | $136.50 | 100.4M | $13.7B | $233M | $455.1M | $13.93B |
| 2023-12-31 | $131.76 | 97.7M | $12.87B | $251.1M | $428.4M | $13.05B |
| 2022-12-31 | $119.44 | 95.8M | $11.44B | $262.9M | $262.9M | $11.44B |
| 2021-12-31 | $85.17 | 94.6M | $8.06B | $340.8M | $440.4M | $8.16B |
| 2020-12-31 | $95.85 | 93.1M | $8.92B | $187.1M | $412.3M | $9.15B |
| 2019-12-31 | $107.49 | 91.63M | $9.85B | $112.3M | $495.5M | $10.23B |
| 2018-12-31 | $71.41 | 95.4M | $6.81B | $141.71M | $388.5M | $7.06B |
| 2017-12-31 | $77.59 | 87.99M | $6.83B | $254.71M | $369.62M | $6.94B |
| 2016-12-31 | $38.70 | 86.56M | $3.35B | $83.27M | -$ | $3.27B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $168.54 | 101M | $17.02B | -$ | $401.8M | $17.42B |
| 2026-03-31 | $131.74 | 100.5M | $13.24B | $266.5M | $406.2M | $13.38B |
| 2025-12-31 | $141.83 | 99.5M | $14.11B | $713M | $415.3M | $13.81B |
| 2025-09-30 | $140.38 | 99.4M | $13.95B | $340.2M | $908.1M | $14.52B |
| 2025-06-30 | $125.69 | 99M | $12.44B | $264M | $439.1M | $12.62B |
| 2025-03-31 | $110.60 | 99.7M | $11.03B | $194.1M | $447.5M | $11.28B |
| 2024-12-31 | $136.50 | 100M | $13.65B | $233M | $455.1M | $13.87B |
| 2024-09-30 | $115.22 | 101.1M | $11.65B | $349.1M | $251.4M | $11.55B |
| 2024-06-30 | $140.11 | 100.8M | $14.12B | $139.7M | $256.2M | $14.24B |
| 2024-03-31 | $141.38 | 99.8M | $14.11B | $396.3M | $511.9M | $14.23B |
| 2023-12-31 | $131.76 | 98.4M | $12.97B | $251.1M | $428.4M | $13.14B |
| 2023-09-30 | $112.50 | 97.9M | $11.01B | $293.7M | $273.6M | $10.99B |